Praxis Precision Medicines (PRAX) Return on Capital Employed (2022 - 2025)
Historic Return on Capital Employed for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to 0.79%.
- Praxis Precision Medicines' Return on Capital Employed fell 3700.0% to 0.79% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.79%, marking a year-over-year decrease of 3700.0%. This contributed to the annual value of 0.81% for FY2024, which is 6700.0% up from last year.
- Praxis Precision Medicines' Return on Capital Employed amounted to 0.79% in Q3 2025, which was down 3700.0% from 0.65% recorded in Q2 2025.
- In the past 5 years, Praxis Precision Medicines' Return on Capital Employed ranged from a high of 0.41% in Q2 2024 and a low of 2.4% during Q1 2023
- Over the past 4 years, Praxis Precision Medicines' median Return on Capital Employed value was 0.83% (recorded in 2025), while the average stood at 1.13%.
- As far as peak fluctuations go, Praxis Precision Medicines' Return on Capital Employed skyrocketed by 15300bps in 2024, and later tumbled by -3700bps in 2025.
- Praxis Precision Medicines' Return on Capital Employed (Quarter) stood at 2.35% in 2022, then surged by 34bps to 1.55% in 2023, then skyrocketed by 69bps to 0.49% in 2024, then crashed by -62bps to 0.79% in 2025.
- Its Return on Capital Employed was 0.79% in Q3 2025, compared to 0.65% in Q2 2025 and 0.53% in Q1 2025.